Cargando…

Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design

BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanwu, Garrard, Lili, Keighley, John, Carlson, Susan, Gajewski, Byron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223445/
https://www.ncbi.nlm.nih.gov/pubmed/28068927
http://dx.doi.org/10.1186/s12884-016-1189-0
_version_ 1782493173600223232
author Zhang, Chuanwu
Garrard, Lili
Keighley, John
Carlson, Susan
Gajewski, Byron
author_facet Zhang, Chuanwu
Garrard, Lili
Keighley, John
Carlson, Susan
Gajewski, Byron
author_sort Zhang, Chuanwu
collection PubMed
description BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical trial to identify whether supplementing pregnant women with docosahexaenoic acid (DHA) has a different effect on the risk subgroup population or not in terms of ePTB prevalence, this study aims to identify potential risk subgroups and risk factors for ePTB, defined as babies born less than 34 weeks of gestation. METHODS: The analysis data (N = 3,994,872) were obtained from CDC and NCHS’ 2014 Natality public data file. The sample was split into independent training and validation cohorts for model generation and model assessment, respectively. Logistic regression and CART models were used to examine potential ePTB risk predictors and their interactions, including mothers’ age, nativity, race, Hispanic origin, marital status, education, pre-pregnancy smoking status, pre-pregnancy BMI, pre-pregnancy diabetes status, pre-pregnancy hypertension status, previous preterm birth status, infertility treatment usage status, fertility enhancing drug usage status, and delivery payment source. RESULTS: Both logistic regression models with either 14 or 10 ePTB risk factors produced the same C-index (0.646) based on the training cohort. The C-index of the logistic regression model based on 10 predictors was 0.645 for the validation cohort. Both C-indexes indicated a good discrimination and acceptable model fit. The CART model identified preterm birth history and race as the most important risk factors, and revealed that the subgroup with a preterm birth history and a race designation as Black had the highest risk for ePTB. The c-index and misclassification rate were 0.579 and 0.034 for the training cohort, and 0.578 and 0.034 for the validation cohort, respectively. CONCLUSIONS: This study revealed 14 maternal characteristic variables that reliably identified risk for ePTB through either logistic regression model and/or a CART model. Moreover, both models efficiently identify risk subgroups for further enrichment clinical trial design.
format Online
Article
Text
id pubmed-5223445
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52234452017-01-11 Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design Zhang, Chuanwu Garrard, Lili Keighley, John Carlson, Susan Gajewski, Byron BMC Pregnancy Childbirth Research Article BACKGROUND: Despite the widely recognized association between the severity of early preterm birth (ePTB) and its related severe diseases, little is known about the potential risk factors of ePTB and the sub-population with high risk of ePTB. Moreover, motivated by a future confirmatory clinical trial to identify whether supplementing pregnant women with docosahexaenoic acid (DHA) has a different effect on the risk subgroup population or not in terms of ePTB prevalence, this study aims to identify potential risk subgroups and risk factors for ePTB, defined as babies born less than 34 weeks of gestation. METHODS: The analysis data (N = 3,994,872) were obtained from CDC and NCHS’ 2014 Natality public data file. The sample was split into independent training and validation cohorts for model generation and model assessment, respectively. Logistic regression and CART models were used to examine potential ePTB risk predictors and their interactions, including mothers’ age, nativity, race, Hispanic origin, marital status, education, pre-pregnancy smoking status, pre-pregnancy BMI, pre-pregnancy diabetes status, pre-pregnancy hypertension status, previous preterm birth status, infertility treatment usage status, fertility enhancing drug usage status, and delivery payment source. RESULTS: Both logistic regression models with either 14 or 10 ePTB risk factors produced the same C-index (0.646) based on the training cohort. The C-index of the logistic regression model based on 10 predictors was 0.645 for the validation cohort. Both C-indexes indicated a good discrimination and acceptable model fit. The CART model identified preterm birth history and race as the most important risk factors, and revealed that the subgroup with a preterm birth history and a race designation as Black had the highest risk for ePTB. The c-index and misclassification rate were 0.579 and 0.034 for the training cohort, and 0.578 and 0.034 for the validation cohort, respectively. CONCLUSIONS: This study revealed 14 maternal characteristic variables that reliably identified risk for ePTB through either logistic regression model and/or a CART model. Moreover, both models efficiently identify risk subgroups for further enrichment clinical trial design. BioMed Central 2017-01-10 /pmc/articles/PMC5223445/ /pubmed/28068927 http://dx.doi.org/10.1186/s12884-016-1189-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Chuanwu
Garrard, Lili
Keighley, John
Carlson, Susan
Gajewski, Byron
Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title_full Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title_fullStr Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title_full_unstemmed Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title_short Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
title_sort subgroup identification of early preterm birth (eptb): informing a future prospective enrichment clinical trial design
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223445/
https://www.ncbi.nlm.nih.gov/pubmed/28068927
http://dx.doi.org/10.1186/s12884-016-1189-0
work_keys_str_mv AT zhangchuanwu subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign
AT garrardlili subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign
AT keighleyjohn subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign
AT carlsonsusan subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign
AT gajewskibyron subgroupidentificationofearlypretermbirtheptbinformingafutureprospectiveenrichmentclinicaltrialdesign